Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07729150 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Reduce HEAT: A Randomized Trial of Wearable Thermal Devices for ADT-Induced Hot Flashes

Name: Reduce HEAT: A Randomized Trial of Wearable Thermal Devices for ADT-Induced Hot Flashes — clinical trial record (NCT07729150)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ReduceHEAT

StatusRecruiting

PhaseNot applicable

SponsorDana-Farber Cancer Institute

Started2026-10-01

View on ClinicalTrials.gov ↗

Amendment history

2026-09-26

Recruitment opened

Dana-Farber Cancer Institute

287 trials monitored

See 33 trials at risk

Prostate Cancer

2,471 trials monitored

See 156 trials at risk

This is a prospective, randomized, non-pharmacologic interventional trial evaluating the effectiveness of the Embr Wave wearable thermal device in reducing hot flash burden in men with prostate cancer receiving androgen deprivation therapy (ADT). Participants will be randomized 1:1 to immediate (12 weeks) versus delayed (after 6 weeks) use of the Embr Wave device. The study aims to determine whether the device reduces vasomotor symptoms using a number of patient-reported outcomes

Trial Details

NCT Number	NCT07729150
Lead Sponsor	Dana-Farber Cancer Institute
Conditions	Prostate Cancer, Hot Flashes, Vasomotor Symptoms
Enrollment	66 participants
Start Date	2026-10-01
Primary Completion	2027-12-31 (estimated)
Study Completion	2028-06-01 (estimated)
Updated on ClinicalTrials.gov	2026-09-25